ArticleJournal of clinical medicine research2019

Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia.

Kanako Tano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.